Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
AccuStem Sciences Logo
AccuStem Sciences Growth Score
33
CB Rank
134147
Heat Score
51
AccuStem Sciences is a life sciences company dedicated to optimizing outcomes for all patients with cancer.
Founded
obfuscation
PublicPost-IPO Equity London, England, United Kingdom1-10 accustem.com
Biotechnology
Health Care
Medical
Overview

AccuStem Sciences
Total Funding
obfuscation
Growth Score
33
Heat Score
51

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score33
-6 pts
in past quarter
Heat Score 51
-9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About AccuStem Sciences

CB Rank
134147
AccuStem Sciences is a life sciences company dedicated to optimizing outcomes for all patients with cancer.
Founded
obfuscation
PublicPost-IPO Equity London, England, United Kingdom1-10 accustem.com
Biotechnology
Health Care
Medical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Accustem Sciences, Inc
Operating Status Active
Stock Symbol  OTCPINK:ACUT
Company Type For Profit
Founders  Gabriele Cerrone
About the Company
AccuStem Sciences is a life sciences company dedicated to optimizing outcomes for all patients with cancer.
Predictions & Insights

Growth Insight

See this Growth Insight
AccuStem Sciences is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

StemPrintER
A 20-gene assay that stratifies early stage breast cancer patients by recurrence risk based on tumor stemness.
MSC Test for Lung Cancer Screening
A blood-based molecular test for lung cancer screening to aid early detection.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - AccuStem Sciences Logo
Post-IPO Equity - AccuStem Sciences
1
obfuscation
Tiziana Life SciencesPost-IPO Equity
obfuscation
Post-IPO Equity - AccuStem Sciences Logo
Post-IPO Equity - AccuStem Sciences
1
obfuscation
Tiziana Life SciencesPost-IPO Equity
obfuscation
Post-IPO Equity - AccuStem Sciences Logo
Post-IPO Equity - AccuStem Sciences
1
obfuscation
Tiziana Life SciencesPost-IPO Equity
obfuscation
Post-IPO Equity - AccuStem Sciences Logo
Post-IPO Equity - AccuStem Sciences
1
obfuscation
Tiziana Life SciencesPost-IPO Equity
obfuscation
Post-IPO Equity - AccuStem Sciences Logo
Post-IPO Equity - AccuStem Sciences
1
obfuscation
Tiziana Life SciencesPost-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - AccuStem Sciences Logo
Post-IPO Equity - AccuStem Sciences
1
obfuscation
Tiziana Life SciencesPost-IPO Equity
obfuscation
Post-IPO Equity - AccuStem Sciences Logo
Post-IPO Equity - AccuStem Sciences
1
obfuscation
Tiziana Life SciencesPost-IPO Equity
obfuscation
Post-IPO Equity - AccuStem Sciences Logo
Post-IPO Equity - AccuStem Sciences
1
obfuscation
Tiziana Life SciencesPost-IPO Equity
obfuscation
Post-IPO Equity - AccuStem Sciences Logo
Post-IPO Equity - AccuStem Sciences
1
obfuscation
Tiziana Life SciencesPost-IPO Equity
obfuscation
Post-IPO Equity - AccuStem Sciences Logo
Post-IPO Equity - AccuStem Sciences
1
obfuscation
Tiziana Life SciencesPost-IPO Equity

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Contacts 2

Employee Profiles

News

News and Press

News•Jan 8, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 4, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 17, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 16, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$158.3KThis year, AccuStem Sciences is projected to spend $158.3K on IT, according to Aberdeen.

Active Website Tech Count

3AccuStem Sciences is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Euro.
Sub-Organizations
Frequently Asked Questions

Where is AccuStem Sciences's headquarters? AccuStem Sciences is located in London, England, United Kingdom.Who invested in AccuStem Sciences? AccuStem Sciences is funded by Tiziana Life Sciences.When was the last funding round for AccuStem Sciences? AccuStem Sciences closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are AccuStem Sciences's competitors? Alternatives and possible competitors to AccuStem Sciences may include Function Health, Freenome, and  Mission Bio.How much funding has AccuStem Sciences raised to date? AccuStem Sciences has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8fe006b 1)
|